Position in GSK
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$249,955
+$53,845 QoQ
Shares Held
4,529
+13.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NFSG Corp holds $11,035,406 across 16 Drug Manufacturers - General names. GSK ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,184 | $4,768,087 | |
| 2 | ABBV |
AbbVie Inc.
|
8,735 | $1,899,775 | |
| 3 | JNJ |
Johnson & Johnson
|
7,319 | $1,789,056 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
7,909 | $1,102,277 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,911 | $350,164 | |
| 6 | PFE |
Pfizer Inc
|
11,084 | $311,238 | |
| 7 | GSK |
GSK plc
This page
|
4,529 | $249,955 | |
| 8 | AMGN |
Amgen Inc
|
615 | $216,387 |
All Filings in GSK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $249,955 | 4,529 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $196,110 | 3,999 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $26,025 | 603 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $25,113 | 654 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $25,297 | 653 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,068 | 209 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $31,600 | 773 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $119,465 | 3,103 | Shares | Sole | 2024-09-11 | |
| 2024-03-31 | $48,871 | 1,140 | Shares | Sole | 2024-04-24 | |
| 2022-12-31 | $11,912 | 339 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $559 | 19 | Shares | Sole | 2022-10-13 | |
| No filing history on record for this holder in this stock. | ||||||